Rubius Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $127,249,000.
Profit Margin
| 2016 | 0 | -11.01M | |
|---|---|---|---|
| 2017 | 0 | -43.84M | |
| 2018 | 0 | -89.19M | |
| 2019 | 0 | -160.46M | |
| 2020 | 0 | -162.04M | |
| 2021 | 0 | -188.82M | |
| 2022 | 0 | -230.86M |
RUBY Income Statement (2016 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating exp. | |||||||
Research and development | 96.41M | 141.58M | 116.10M | 112.41M | 51.76M | 21.22M | 8.40M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 127.24M | 194.61M | 166.44M | 169.60M | 91.66M | 43.26M | 10.85M |
Operating income | -178.44M | -194.61M | -166.44M | -169.60M | -91.66M | -43.26M | -10.85M |
Other income (expenses), net | -1.22M | -1.93M | -1.28M | 6.14M | 2.46M | -583K | -15K |
Income before tax | -179.66M | -196.54M | -167.73M | -163.45M | -89.19M | -43.84M | -11.01M |
Income tax expense | 51.19M | -7.72M | -5.69M | -2.99M | 2.93M | 309K | 133K |
Net income | -230.86M | -188.82M | -162.04M | -160.46M | -89.19M | -43.84M | -11.01M |
Earnings per share | |||||||
Basic EPS | -2.56 | -2.15 | -2.01 | -2.04 | -2.27 | -5.13 | -1.29 |
Diluted EPS | -2.56 | -2.15 | -2.01 | -2.04 | -2.27 | -5.13 | -1.29 |
| Data source | Data source | Data source | Data source | Data source |